Pathogenesis of steatohepatitis: insights from the study of animal models
- PMID: 17619535
Pathogenesis of steatohepatitis: insights from the study of animal models
Abstract
Non-alcoholic steatohepatitis (NASH) is a disease of expanded clinical importance. Its pathogenesis remains poorly understood. Tools to identify patients at risk and targeted treatments are lacking. The aim of this work was to analyse potential pathogenic mechanisms for inflammatory recruitment and fibrogenesis in NASH, using animal models. We demonstrated that oxidative stress, invariably associated with NASH, is a primary and necessary event for disease progression. Inhibition of stress-activated transcription factor NF-chiB prevents NASH. NF-chiB therefore appears as a pathogenic link between oxidative stress and NASH. Increased lipid beta-oxidation in NASH could generate oxidative stress. We used a potent inducer of PPAR-alpha to stimulate beta-oxidation in a model of steatohepatitis. Such treatment induced a complete clearance of steatosis together with a significant reduction of oxidative stress and oxidative injuries and prevention of inflammation and fibrosis. Thus in a situation of steatosis, stimulation of lipid combustion depletes the substrates for lipid peroxidation and thereby decreases oxidative stress. This effect is sufficiently powerful to prevent the development of steatohepatitis. We demonstrated that leptin is a pro-fibrogenic adipocytokine and is implicated in the regulation of liver regeneration. Leptin plays this crucial physiological role in hepatic wound healing by controlling the production and the activation of cytokines. The insulin sensitising drugs thiazolidinediones have antiinflammatory and anti-fibrotic properties in rats. We demonstrated that such drugs are poorly effective in the treatment of preestablished hepatic fibrosis in rats and unable to prevent fibrogenesis in vitro as well as in vivo in mice. Direct anti-fibrotic effect of such substances remains to be demonstrated in humans. In conclusion, our work demonstrates the importance of oxidative stress in the pathogenesis of NASH, the role of intrahepatic lipid overload and underlies the links between adipose tissue and the liver.
Similar articles
-
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x. J Gastroenterol Hepatol. 2012. PMID: 21929649
-
Etiopathogenesis of nonalcoholic steatohepatitis.Semin Liver Dis. 2001;21(1):27-41. doi: 10.1055/s-2001-12927. Semin Liver Dis. 2001. PMID: 11296694 Review.
-
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.Hepatology. 2007 Nov;46(5):1392-403. doi: 10.1002/hep.21874. Hepatology. 2007. PMID: 17929294
-
[Role of oxidative stress in non-alcoholic steatohepatitis].Nihon Rinsho. 2006 Jun;64(6):1077-82. Nihon Rinsho. 2006. PMID: 16768112 Review. Japanese.
-
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.Gastroenterology. 2007 Jan;132(1):282-93. doi: 10.1053/j.gastro.2006.10.014. Epub 2006 Oct 12. Gastroenterology. 2007. PMID: 17241878
Cited by
-
Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats.World J Gastroenterol. 2008 May 28;14(20):3254-8. doi: 10.3748/wjg.14.3254. World J Gastroenterol. 2008. PMID: 18506935 Free PMC article.
-
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease.PPAR Res. 2009;2009:952734. doi: 10.1155/2009/952734. Epub 2010 Mar 16. PPAR Res. 2009. PMID: 20300478 Free PMC article.
-
Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates.J Clin Invest. 2009 Feb;119(2):323-35. doi: 10.1172/JCI32661. Epub 2009 Jan 19. J Clin Invest. 2009. PMID: 19147984 Free PMC article.
-
Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Pemafibrate, on Metabolic Parameters: A Retrospective Longitudinal Study.Biomedicines. 2022 Feb 8;10(2):401. doi: 10.3390/biomedicines10020401. Biomedicines. 2022. PMID: 35203610 Free PMC article.
-
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model.J Inflamm Res. 2014 Oct 8;7:151-8. doi: 10.2147/JIR.S50508. eCollection 2014. J Inflamm Res. 2014. PMID: 25336983 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources